Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysisMélanie Drolet, Petra J. Woestenberg, Bo Yu et al.|The Lancet|2019Cited by 1.3k
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021Julia W. Gargano, Sara E. Oliver, Megan Wallace et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 602
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018Kristen Kreisel, Hillard Weinstock, Ian H. Spicknall et al.|Sexually Transmitted Diseases|2021Cited by 535
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United StatesSarah A. Collier, Michael J. Beach, Li Deng et al.|Emerging infectious diseases|2020Cited by 318
Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United StatesKayla Saadeh, Michael J. Silverberg, Ina Park et al.|Vaccine|2019Cited by 16